KYMR · Company research
Kymera Therapeutics, Inc. Common Stock (KYMR): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 108.35 | $10,995,841,696 | 10871364696 | — | — | — | 169.1667953230769231 | 7.2856040963229565 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.